MENU
+Compare
THTX
Stock ticker: NASDAQ
AS OF
Aug 19, 04:59 PM (EDT)
Price
$3.23
Change
-$0.01 (-0.31%)
Capitalization
149.42M

THTX Theratechnologies Forecast, Technical & Fundamental Analysis

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients... Show more

THTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for THTX with price predictions
Aug 18, 2025

THTX in +0.78% Uptrend, rising for three consecutive days on August 18, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where THTX advanced for three days, in of 205 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 22, 2025. You may want to consider a long position or call options on THTX as a result. In of 114 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Moving Average Convergence Divergence Histogram (MACD) for THTX turned negative on July 25, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at .

THTX broke above its upper Bollinger Band on August 13, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. THTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (19.515). P/E Ratio (0.000) is within average values for comparable stocks, (50.244). THTX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.850). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (1.893) is also within normal values, averaging (300.688).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. THTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
THTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a pharmaceutical company, which engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV)

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2015, rue Peel
Phone
+1 514 336-7800
Employees
58
Web
https://www.theratech.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTCFF0.390.10
+35.17%
Ocumetics Technology Corp.
QBEIF14.40N/A
N/A
QBE Insurance Group Ltd.
SSSAF40.02N/A
N/A
SHURGARD SELF STORAGE LTD.
ECIA0.25N/A
N/A
Encision, Inc.
RYBIF16.00N/A
N/A
Ryobi Ltd.

THTX and Stocks

Correlation & Price change

A.I.dvisor tells us that THTX and THRD have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that THTX and THRD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To THTX
1D Price
Change %
THTX100%
+0.15%
THRD - THTX
27%
Poorly correlated
N/A
GNPX - THTX
27%
Poorly correlated
-10.04%
SPRC - THTX
26%
Poorly correlated
+0.67%
HOWL - THTX
26%
Poorly correlated
N/A
KOD - THTX
24%
Poorly correlated
+6.43%
More